A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Clinical trial NCT05202301 · COMPLETED

Trial details

NCT number: NCT05202301
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2022-01-15
Primary completion: 2025-07-15
Enrollment: 13779

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.